videos
Prognosis

Prognosis

December 16, 2021
Anthony Wang, MD
Anthony Wang, MD

Neurosurgery

Share

Transcript

Taken as a whole, the prognosis for glioblastoma is very poor. The majority of patients don’t live more than two years and recurrence is universal. Prognosis depends somewhat on molecular genetic subtypes of glioblastoma, and most major brain tumor centers now perform testing to differentiate these subtypes. Beyond stratifying for prognosis, molecular genetic testing can sometimes determine eligibility for clinical trials and occasionally identify targeted therapies that might be useful that are not part of the standard treatment paradigm.

Watch Next

1:04
Conclusion

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
1:26
Clinical Trials

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
0:46
Outcome

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
0:20
Recovery

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
0:52
After Surgery

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
0:29
Alternative Treatment

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
0:21
Insurance

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
1:20
Diagnosis

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
0:36
Symptoms

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
1:05
Causes

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
1:07
Overview

by: Anthony Wang, MD

Anthony Wang, MD
Anthony Wang, MD

Neurosurgery
More Videos
Share this video

Share this with your social Community

or copy link